Support Our Coronavirus Research

Be Part of the Solution to COVID-19

Lives and economies depend on effective vaccines and treatments — and the success of these interventions depends on you.

Join us.

COVID-19 Research at Fred Hutch

Philanthropy makes it possible for science to move at the speed of the pandemic. We’ve learned an incredible amount about this virus in a very short time, thanks to the generosity of donors from across the country.

With cases surging around the world, we need vaccines to prevent infection and treatments that can stop COVID-19 before it becomes debilitating or deadly. Your support will play a vital role in bringing these desperately needed vaccines and treatments within reach.

  • We’re leading massive, international vaccine trials as part of the U.S. government’s Operation Warp Speed, a monumental effort to test, develop, and distribute safe and effective coronavirus vaccines in record time.
  • In September 2020, we are opening the COVID-19 Clinical Research Center at Fred Hutch, a unique regional hub for vaccine trials and clinical studies of the virus and emerging treatments.

Together, these ambitious initiatives have the potential to turn the tide of the pandemic.

We’re raising $10 million for COVID-19 research, including $2 million in philanthropic startup funding to get these bold projects off the ground. Your investment in our work, together with government and industry funding, will protect lives and transform the future.

Fuel Leading-Edge Research

In the past six months, supporters like you have donated more than $7 million to the COVID-19 Research Fund at Fred Hutch, helping to launch projects that are already delivering results. In addition to the vaccine trials and clinical research center, philanthropic support is fueling these high-priority projects:

  • Discovering antibodies in people infected with the coronavirus to inform new therapeutics and vaccines. With donor support, a Fred Hutch team identified an extremely potent neutralizing antibody that stops the virus from infecting vulnerable cells.
  • Following health care workers, first responders, and others at high risk for the virus to gain detailed insight into how our bodies react from the earliest days of infection. Learn more about the Seattle COVID-19 Cohort Study.
  • Studying our own workforce to understand prevalence of COVID-19 on our campus and keep transmission as close to zero as possible. As our lab-based researchers returned to campus and ramped up their work, we modeled a safe path forward for other organizations and businesses.
  • Reducing the pandemic's disproportionate effect on communities of color and other health inequities. 
  • Testing outside-the-box ideas through donor-funded pilot awards that allow scientists to generate the proof of concept they need to attract larger grants.

Philanthropic support from people like you allows us to move faster and explore the newest, most daring ideas. By fostering innovation early in the research process, you make it possible for us to build the evidence we need to secure government funding, foundation grants, and industry partnerships — and to turn promising ideas into proven solutions that will halt the pandemic and save lives worldwide.

Thank you for your belief in the power of research.

Dr. Larry Corey
Fred Hutch is at the forefront of an unprecedented, global effort to conceive of and test safe and effective vaccines against this virus. Dr. Larry Corey, a world-renowned virologist and Fred Hutch’s president and director emeritus, is co-leading this extraordinary effort.

Support COVID-19 Research

$7.2 M

Raised to Date
Thank you for your generous support!

1,500+

Donors
More than half are new donors.

$10 M

Summer 2020 Goal
To support COVID-19 research.

Why Does Fred Hutch Study Viruses?

Our pioneering work in bone marrow transplantation revealed the urgent need to protect transplant patients from deadly infections, which launched our quest to gain an in-depth understanding of the immune system.

Today, we’re known for our expertise in virology and infectious disease. We are working in the laboratory, the clinic, and the cloud to find better ways to detect, prevent, and treat viruses and other infections to protect patients and communities. Working across disciplines, we are studying how HIV and other viruses evolve, learning how pathogens cause cancers, and developing and advancing treatments that harness patients’ own immune systems to fight disease. We track epidemics to guide public health officials’ strategies to contain outbreaks of diseases like Zika, Ebola, and now COVID-19. And we’re on the leading edge of developing vaccines to prevent HIV, with active research projects in Kenya, South Africa, Uganda, and more than 40 other countries. 

Your gift to our COVID-19 Research Fund will have immediate and long-term impact. Please give today.

HVTN employee working in the lab

How Vaccines Are Developed

Fred Hutch is at the center of an unprecedented, global effort to develop, test, and deliver safe and effective vaccines against the virus. It's about saving lives, protecting our way of life, and making history. Here's how it will happen.

Learn More
Dr. Julie McElrath

COVID-19 Research

Fred Hutch researchers are working together to stop this pandemic and prevent the next one — people like Dr. Julie McElrath, who is leading multiple research studies and operating a key laboratory for COVID-19 vaccine trials. 
    

Learn More
Last Modified, September 15, 2020